Martí Duran-Ferrer
Grupo de investigación
- Epigenómica biomédica Post-doctoral researcher (R2A)
Publicaciones destacadas
-
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Autores:Referencia: Blood 2021. -
Chronic lymphocytic leukemias with trisomy 12 show a distinct DNA methylation profile linked to altered chromatin activation
Autores:Referencia: Haematologica 2020. -
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Autores:Referencia: Blood 2020. -
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Autores:Referencia: Genome Research 2020. -
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
Autores:Referencia: Clinical Epigenetics 2019. -
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia
Autores:Referencia: International Journal Of Cancer 2019. -
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
Autores:Referencia: Nature Medicine 2018. -
In silico deconvolution and purification of cancer epigenomes
Autores:Referencia: Oncoscience 2017. -
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
Autores:Referencia: Cancer Cell 2016. -
Whole-genome fingerprint of the DNA methylome during human B cell differentiation
Autores:Referencia: Nature Genetics 2015.